Longevity & Aging
IDO1 inhibition (blocking tryptophan->kynurenine) restores astrocyte glycolysis and rescues memory across amyloid and tau Alzheimer's models
In plain terms: Can blocking an enzyme (IDO1) that both amyloid and tau switch on rescue memory in Alzheimer's models?
Part of: • Aging
One strong mouse/cell study (Science 2024) shows amyloid and tau activate astrocytic IDO1->kynurenine, choking brain glucose use, and that blocking IDO1 restores memory; independent data confirm kynurenine pathway disturbance in human AD but the memory-rescue causal claim rests on this single lab.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Audit note (2026-07-14 deep audit, re-graded strong-support→leans-support): Same scope-conflation as lmhr-ldl-causes-plaque. This is an INTERVENTION claim (does inhibiting IDO1 restore memory?).
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Minhas 2024 · Science | animal | supports | high | Cited paper: Abeta & tau activate astrocytic IDO1->KYN, suppressing glycolysis (AhR-dependent); IDO1 inhibition restores hippocampal LTP & memory across AD mouse models + AD-patient cocultures. |
| Johnson LA 2024 · Science | mechanism | supports | moderate | [preclinical - no human IDO1-inhibitor AD trials exist] Science commentary/news piece (one-sentence abstract): 'Kynurenine pathway inhibition reverses deficits in Alzheimer's mouse models.' |
| Bakker 2023 · Brain Behav Immun | observational | mixed | moderate | Plasma/CSF kynurenines relate variably to AD pathology markers; pathway altered but associations modest/inconsistent. |
| Cespedes 2022 · Neurobiol Dis | observational | mixed | moderate | [ASSOCIATION not INTERVENTION - establishes kynurenine-pathway involvement in AD, but does NOT test whether INHIBITING IDO1 restores memory; scope-mismatched to this intervention claim] Systemic kynurenine-pathway perturbations precede progression to dementia independently of amyloid; human cohort, corroborates pathway relevance. |
| Dos Reis 2025 · Alzheimers Dement | observational | mixed | moderate | [ASSOCIATION not INTERVENTION - establishes kynurenine-pathway involvement in AD, but does NOT test whether INHIBITING IDO1 restores memory; scope-mismatched to this intervention claim] Independent human data: kynurenine-pathway metabolite alterations in AD and Down-syndrome AD; corroborates pathway, not the intervention. |
| Souza 2016 · Brain Behav Immun | animal | supports | moderate | IDO inhibitor 1-MT prevented memory and emotional deficits after intracerebroventricular amyloid-beta in mice. |
| Świątek G 2025 · Int J Mol Sci | animal | supports | low | [preclinical - no human IDO1-inhibitor AD trials exist] Rat study (STZ-induced sporadic AD model, n per group not stated in abstract): minocycline treatment (7 days, 35 mg/kg) improved reference memory (Morris water maze) and reduced anxiet |
| Zhang 2026 · Horm Behav | animal | supports | moderate | In APP/PS1 female mice, IDO1 inhibitor 1-MT reversed cognitive impairment and normalized Trp/Kyn metabolism. |
| Qian 2021 · Theranostics | animal | contradicts | moderate | Directional wrinkle: AhR ACTIVATION (not inhibition) rescues AD-mouse cognition via neprilysin; complicates the IDO1->KYN->AhR-as-harmful framing. |
| Almulla 2022 · J Alzheimers Dis | meta-analysis | mixed | moderate | [ASSOCIATION not INTERVENTION - establishes kynurenine-pathway involvement in AD, but does NOT test whether INHIBITING IDO1 restores memory; scope-mismatched to this intervention claim] Meta-analysis: kynurenine/TRYCAT pathway is dysregulated in AD; supports the upstream premise (KYN disturbance) but not the IDO1-inhibition memory rescue. |
| Souza 2017 · Behav Brain Res | animal | supports | low | Swimming exercise reduced IDO/kynurenine activation and improved amyloid-beta-induced behavioral disturbances in mice, implicating IDO1 in cognitive impairment. |
| Minhas 2024 · bioRxiv | animal | supports | moderate | Preprint of the Science study showing IDO1 inhibition restores hippocampal glucose metabolism and rescues memory across amyloid and tau models. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.